Galectin Therapeutics Inc.GALTNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank20
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-37.30M
↓ 32% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-28.30M
Historical baseline
PeriodValueYoY Change
TTM$-37.30M+20.7%
2024$-47.05M-14.6%
2023$-41.07M-5.9%
2022$-38.78M-27.0%
2021$-30.53M-30.1%
2020$-23.46M-76.5%
2019$-13.29M+4.4%
2018$-13.90M+14.4%
2017$-16.23M+24.3%
2016$-21.44M-